Difficulties evaluating hematological response in patients with multiple myeloma and dialysis - dependent renal impairment
- Authors: Rekhtina IG1, Mendeleeva LP1, Soboleva NP1
-
Affiliations:
- National Research Center for Hematology
- Issue: Vol 91, No 7 (2019)
- Pages: 70-74
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33612
- DOI: https://doi.org/10.26442/00403660.2019.07.000215
- ID: 33612
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I G Rekhtina
National Research Center for Hematology
Email: rekhtina.i@blood.ru
д.м.н., зав. отд-нием химиотерапии плазмоклеточных дискразий ФГБУ «НМИЦ гематологии» Минздрава России; ORCID: 0000-0001-5440-4340 Moscow, Russia
L P Mendeleeva
National Research Center for Hematologyд.м.н., проф., зам. генерального директора по научной работе и инновациям, зав. отд. высокодозной химиотерапии парапротеинемических гемобластозов ФГБУ «НМИЦ гематологии» ГНЦ Минздрава России; ORCID: 0000-0002-4966-8146 Moscow, Russia
N P Soboleva
National Research Center for Hematologyврач клинической лабораторной диагностики центральной клинико-диагностической лаб. ФГБУ «НМИЦ гематологии» Минздрава России; ORCID: 0000-0002-1903-2446 Moscow, Russia
References
- Dispenzieri A, Kyle R, Merlini G, Miguel J.S, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau J.L, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos M.V, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar S.V, Durie B.G.M. International Myeloma Working Group guidelines for serum - free light chain analysis in multiple myeloma and related disorders. Leukemia. 2008;1-10. doi: 10.1038/leu.2008.307
- Bradwell A.R. Serum free light chain analysis plus hevylite. 7th ed. UK (Birmingham): The Binding Site Group, 2015.
- Kumar S, Paiva B, Anderson K.C, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos M.V, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng W.J, Usmani S.Z, Zamagni E, Shimizu K, Jagannath S, Johnsen H.E, Terpos E, Reiman A, Kyle R.A, Sonneveld P, Richardson P.G, Mc Carthy P, Ludwig H, Chen W, Cavo M, Harousseau J.L, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar S.V, Miguel J.S, Avet-Loiseau H. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17:e328-46. doi: 10.1016/S1470-2045(16)30206-6
- Dimopoulos M, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E, Goldschmidt H, Joshua D, Orlowski R, Powles R, Vesole D, Garderet L, Einsele H, Palumbo A, Cavo M, Richardson P, Moreau P, San Miguel J, Rajkumar S, Durie B, Terpos E. International Myeloma Working Group recommendations for the diagnosis and management of myeloma - related renal impairment. J Clin Oncol. 2016;34:1544-57. doi: 10.1200/JCO.2015.65
- Moreau P, San Miguel J, Sonneveld P, Mateos M.V, Zamagni E, Avet-Loiseau H, Hajek R, Dimopoulos M.A, Ludwig H, Einsele H, Zweegman S, Facon T, Cavo M, Terpos E, Goldschmidt H, Attal M, Buske C. ESMO Guidelines Committee. Multiple myeloma: ESMO Clinical Practice Guidelinesfor diagnosis, treatment and follow - up. Ann Oncol. 2017;28(suppl 4):iv52-iv61. doi: 10.1093/annonc/ mdx096
![](/img/style/loading.gif)